Company Filing History:
Years Active: 2022-2024
Title: Brian John Sutton: Innovator in Anti-IgE Antibodies
Introduction
Brian John Sutton is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the development of anti-IgE antibodies. With a total of 2 patents, his work focuses on improving treatments for disorders caused by IgE.
Latest Patents
Sutton's latest patents revolve around improved anti-IgE antibodies and antigen binding agents. These inventions target IgE for use in treating disorders such as allergic responses and certain autoimmune responses. His work specifically addresses disorders caused by the interaction of IgE with the FcεRI receptor. The improved anti-IgE antibodies may exhibit enhanced affinity for IgE and improved interactions with the Cε2 domain of IgE. Additionally, these antibodies may possess the ability to disassociate IgE from the FcεRI receptor at pharmaceutically relevant concentrations. Sutton's innovations aim to provide novel treatments for IgE-mediated disorders by targeting both free IgE and IgE complexed with the FcεRI receptor.
Career Highlights
Brian John Sutton is currently associated with Ucb Biopharma Srl, where he continues to advance his research in immunology. His work has the potential to significantly impact the treatment of allergic and autoimmune disorders.
Collaborations
Sutton has collaborated with notable colleagues such as Ralph Adams and Thomas Allen Ceska, contributing to the advancement of his research and innovations.
Conclusion
Brian John Sutton is a prominent inventor whose work in anti-IgE antibodies is paving the way for improved treatments for IgE-mediated disorders. His contributions to the field of immunology are noteworthy and hold promise for future advancements.